[
  {
    "ts": "2026-01-12T13:30:00+00:00",
    "headline": "PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference",
    "summary": "PTC Therapeutics, Inc. (NASDAQ: PTCT) today provided an update on the Company's progress and its outlook for 2026. Matthew B. Klein, M.D., Chief Executive Officer of PTC, will discuss these updates at the Company's presentation at the J.P. Morgan 2026 Healthcare Conference on Monday, January 12, 2026, at 9:00 a.m. PST / 12:00 p.m. EST.",
    "url": "https://finance.yahoo.com/news/ptc-therapeutics-provides-j-p-133000897.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "a5735786-5c69-34e4-8f81-e9cc4b290d39",
      "content": {
        "id": "a5735786-5c69-34e4-8f81-e9cc4b290d39",
        "contentType": "STORY",
        "title": "PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference",
        "description": "",
        "summary": "PTC Therapeutics, Inc. (NASDAQ: PTCT) today provided an update on the Company's progress and its outlook for 2026. Matthew B. Klein, M.D., Chief Executive Officer of PTC, will discuss these updates at the Company's presentation at the J.P. Morgan 2026 Healthcare Conference on Monday, January 12, 2026, at 9:00 a.m. PST / 12:00 p.m. EST.",
        "pubDate": "2026-01-12T13:30:00Z",
        "displayTime": "2026-01-12T13:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/248c01ded71fcb9955aa8e985a816d70",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/q4gDxKheD5SSICLo2OY7fw--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/248c01ded71fcb9955aa8e985a816d70.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2y.9Xicx.CiThILCxhoKHw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/248c01ded71fcb9955aa8e985a816d70.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ptc-therapeutics-provides-j-p-133000897.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ptc-therapeutics-provides-j-p-133000897.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PTCT"
            },
            {
              "symbol": "PTC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]